Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer
Parang, B.; Yoffe, L.; Khan, R.; Li, Z.; Nagiec, M.; Gardner, E. E.; Shieh, Y.; Heise, R. S.; Saxena, A.; Altorki, N.; Blenis, J.
Show abstract
Recent studies show that genetic sequencing can not fully explain drug resistance in non-small cell lung cancer (NSCLC), suggesting undiscovered non-genetic mechanisms that can enable cancer cell survival. Propionate metabolism is the pathway by which odd-chain fatty acids, branched chain amino acids, and cholesterol are metabolized. We have previously shown that methylmalonic acid (MMA), a byproduct of propionate metabolism that accumulates when the pathway is disrupted, can activate epithelial-to-mesenchymal transition (EMT) in cell lines. But the clinical significance of propionate metabolism in cancer patients is not known. Here we show, for the first time, that propionate metabolism is dysregulated in patients with non-small cell lung cancer. MMA is elevated in lung tumors and in the serum of patients with metastatic NSCLC. Metabolism of cobalamin associated B (MMAB), a key regulatory gene of propionate metabolism, is downregulated in NSCLC and drug-tolerant persister cells, leading to MMA accumulation and EMT activation. We show that restoring expression of MMAB in NSCLC enhances targeted therapy and suppresses TGFB signaling. These findings reveal propionate metabolism dysregulation as a non-genetic mechanism of drug resistance and highlight propionate metabolism as a potential therapeutic target.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis 95%
- SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma 94%
- Targeting the glucose-insulin link in head and neck squamous cell carcinoma induces cytotoxic oxidative stress and inhibits cancer growth 93%
Similar papers in this journal
- A Genomically and Clinically Annotated Patient Derived Xenograft (PDX) Resource for Preclinical Research in Non-Small Cell Lung Cancer 94%
- Apolipoprotein E2 Promotes Melanoma Growth, Metastasis, and Protein Synthesis via the LRP1 Receptor 93%
- FGFR1 is critical for Rbl2 loss-driven tumor development and requires PLCG1 activation for continued growth of small cell lung cancer 93%
Similar papers in this journal
- SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma 94%
- Epithelial HO-1 regulates iron availability and promotes colonic tumorigenesis in a context-dependent manner 93%
- mTOR Inhibition Overcomes RSK3-mediated Resistance to BET Inhibitors in Small Cell Lung Cancer 93%
Similar papers in this journal
- Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction 95%
- Intraoperative arteriovenous patient sampling to assess in situ non-small cell lung cancer metabolism 94%
- Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.